HDAC9 and hereditary pheochromocytoma-paraganglioma: Vorinostat, a histone deacetylase (HDAC) inhibitor, has shown promise in pheochromocytoma imaging and therapy for potentially increasing the uptake of radioactive tracers like 123I-MIBG [102].